R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis
about
Children's Oncology Group's 2013 blueprint for research: bone tumorsTeprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes.Can we unlock the potential of IGF-1R inhibition in cancer therapy?Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma.Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumorsPI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R) : implications for inhibition of the IGF-1R signal.Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors.Ewing's sarcoma: overcoming the therapeutic plateau.Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.Let-7a functions as a tumor suppressor in Ewing's sarcoma cell lines partly by targeting cyclin-dependent kinase 6.Targeted therapy in rare cancers--adopting the orphans.Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy.Prognostic and therapeutic relevance of the IGF pathway in Ewing's sarcoma patients.Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma.Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors.
P2860
Q27027664-3E2E20D7-C1F1-4158-B9EF-CE77D72BEF37Q34130987-6C44A898-C47A-4CA5-AB69-F788FEA56046Q34336988-457A307C-E836-4212-96B5-0E4CB0EFA587Q34702270-9F1E5DE9-779C-4B3C-B006-CFDD8E4CF4C7Q35224188-90096E6B-A2B8-4317-A743-8DDD8A188D99Q35763861-FBAF384C-BD7E-425D-808C-A7EF9CE9884DQ37029389-CD9BA028-6D95-4ECC-8741-3E8D6E69A57EQ37362118-B737BEE6-F726-4EB9-8D41-E225666FBE98Q37487126-F1E12DFC-BED0-46E5-A2B4-61A19D8BA492Q37565298-A4C16240-FDC7-4CF3-837C-10E0B465695CQ37617616-27A66C05-60B2-4811-B825-DDFC7C645F62Q38042324-00DB216D-30EA-4D3E-9A64-C4C90FE272CCQ38243878-E2743777-8DC4-419C-980F-68E9C1D90882Q39215732-C9725EC2-C6EC-4F9E-8E8E-712B341EE737Q39314094-C38E8D14-CB30-4A64-8343-00AFCB6E7931Q43144913-161F3AE9-6294-465C-B685-03216D818E2DQ47896312-7C1728AB-2E56-4F27-9ED6-3EF4EFEF7511
P2860
R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
R1507, an anti-insulin-like gr ...... gence at the IGF/IGFR/Akt axis
@ast
R1507, an anti-insulin-like gr ...... gence at the IGF/IGFR/Akt axis
@en
R1507, an anti-insulin-like gr ...... gence at the IGF/IGFR/Akt axis
@nl
type
label
R1507, an anti-insulin-like gr ...... gence at the IGF/IGFR/Akt axis
@ast
R1507, an anti-insulin-like gr ...... gence at the IGF/IGFR/Akt axis
@en
R1507, an anti-insulin-like gr ...... gence at the IGF/IGFR/Akt axis
@nl
prefLabel
R1507, an anti-insulin-like gr ...... gence at the IGF/IGFR/Akt axis
@ast
R1507, an anti-insulin-like gr ...... gence at the IGF/IGFR/Akt axis
@en
R1507, an anti-insulin-like gr ...... gence at the IGF/IGFR/Akt axis
@nl
P2093
P2860
P1433
P1476
R1507, an anti-insulin-like gr ...... gence at the IGF/IGFR/Akt axis
@en
P2093
Helen J Huang
Henrique A Parsons
Jonathan C Trent
Jordi Rodon
Klaus-Peter Kuenkele
Laura S Angelo
Michael Sun
P2860
P304
P356
10.1371/JOURNAL.PONE.0026060
P407
P577
2011-10-11T00:00:00Z